Blood Products Forum

GBC 5

Blood Products Forum

09:00 ~ 13:00 Rose 5F

Summary
In terms of plasma derivatives, it is crucial to establish national systems for safety management and emergency responses. At the GBC 2018, we will compare each country’s blood safety management systems. Furthermore, at the 3rd Meeting of National Control Laboratories for Biologicals in the Western Pacific, which is linked to the GBC 2018, we will talk about the efficacy of immunoglobulin and trends on safety and quality control.
Date
June 28(Thu), 09:00 ~ 13:00
Venue
Rose 5F Venue Guide

Schedule

Time Title Presentation File
Blood Products
Chair : Hyun Ok Kim (Yonsei University College of Medicine)
09:00~09:40(40')

[Keynote Speech] Rh D blood group conversion using transcription activator-like effector nucleases

Hyongbum Kim / Yonsei University College of Medicine

09:40~09:50(10')

Q & A

-
[Session1] Blood Safety and Regulation
09:50~10:20(30')

Safety management of blood for transfusion in Korea

So-Yong Kwon / Korean Red Cross, Central Lab Center

-
10:20~10:50(30')

Vector-borne infection and transfusion safety

Roger Y Dodd / American Red Cross Holland Laboratory

-
10:50~11:20(30')

Implementation of GMP in Blood Establishments

Lesley Bust / Quality Manager, ISBT

11:20~11:30(10')

Coffee Break

-
11:30~12:30(60')

The challenge of replacing DEHP as plasticizer for blood bags

Dirk De Korte, Ph.D, / R&D of Sanquin Blood Bank, Netherland

Current status and regulatory issues of pathogen inactivation technologies for cellular blood product

Sinyoung Kim / Yonsei University College of Medicine

-